National Comparative Audit of Blood Transfusion

Upcoming audits

• Spring 2025 - Major Haemorrhage audit
• Spring 2026 - Anti-D audit

Our audits in progress are:

• 2024 Audit of NICE Quality Standard QS138

Our latest reports published are:

• 2024 National Comparative Audit of Bedside Transfusion Practice (Re-audit)
• 2022 Audit of Patient Blood Management in Elective Paediatric Surgery
• 2022 Audit of Acute Upper Gastrointestinal Bleeding and the use of Blood

Go the audits

What is the National Comparative Audit?

The National Comparative Audit of Blood Transfusion (NCABT) is a programme of clinical audits which looks at the use and administration of blood and blood components in NHS and independent hospitals in England. We also invite participation from the blood services in Northern Ireland, Scotland and Wales.

The objective of the programme is to provide evidence blood is being ordered and used appropriately, administered safely, to highlight where practice is deviating from guidelines to the possible detriment of patient care.

The programme has been in operation since 2003 and is funded entirely by NHS Blood and Transplant through the blood pricing mechanism, and is one of the largest independently funded audit programmes in the UK. No charge is made to UK hospitals participating in it.

Contact

John Grant-Casey
National Comparative Audit Programme Manager
Telephone: 07720 275388
john.grant-casey@nhsbt.nhs.uk 

Paul Davies
Senior Clinical Audit Facilitator
Telephone: 07385 387918
paul.davies@nhsbt.nhs.uk 

If you would like to sign up for alerts about the programme please send an email to NCA@nhsbt.nhs.uk with the subject NCA Alerts and include your name, job title and organisation.